Skip to main content

Medtronic plc

corporate_fare Company Profile

Medtronic plc

MDT·NYSE·Industrial Applications And Services·CIK 0001613103

Medtronic plc, headquartered in Galway, Ireland, is a global healthcare technology company. Founded in 1949, Medtronic serves healthcare systems, physicians, clinicians, and patients in over 150 countries worldwide. The company operates with a mission established in 1960: "to contribute to human welfare by the application of biomedical engineering in the research, design, manufacture, and sale of products to alleviate pain, restore health, and extend life." Medtronic's business strategy focuses on three key areas. First, it aims to accelerate innovation-driven growth by bringing inventive and disruptive technology to healthcare opportunities, leveraging recent product launches and a robust pipeline to meet patient needs and increase product adoption globally. Second, the company strives to deliver superior outcomes and better experiences for patients and providers by understanding customer challenges and creating agile partnerships to deploy therapies. Third, Medtronic seeks to turn data, AI, and automation into action, utilizing new technology, AI, and data analytics to tailor therapies in real-time, facilitate remote monitoring and care delivery, and establish new standards of care. The company has three reportable segments that primarily develop, manufacture, distribute, and sell device-based medical therapies and services: the Cardiovascular Portfolio, the Neuroscience Portfolio, and the Medical Surgical Portfolio.

Medtronic plc (NYSE:MDT) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 38 items for MDT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-15, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for MDT spans 425, SC TO-I, 10-Q, 8-K.

Recent high-impact activity:

  • Medtronic Completes MiniMed Split-Off, Diabetes Unit Begins Trading as MMED
  • Medtronic's MiniMed Exchange Offer Oversubscribed at 18.3% Acceptance
  • Medtronic Sets Final Exchange Ratio of 4.5939x for MiniMed Split-Off
  • Medtronic Files Formal Tender Offer for $5.3B MiniMed Split-Off
  • Medtronic Launches Exchange Offer to Complete MiniMed Separation

Financial Snapshot

Fiscal year ended April 24, 2026
Revenue
$36.36B
Net Income
$4.8B
Diluted EPS
$3.73
Op. Cash Flow
$7.33B
Free Cash Flow
$5.43B
Gross Profit
$23.64B
Operating Income
$6.47B
Cash & Equivalents
$1.95B
Total Debt
$1.79B
Debt / Equity
0.04×
Net Margin
13.2%
Shares Outstanding
1.28B sh
Source: 10-K · filed 2026-06-18 · accession 0001628280-26-044354

Short Interest & Short Volume

2.93 days to cover

FINRA reported short interest of 139,004,337 shares in MDT as of the October 15, 2026 settlement, a 247.7% increase from the prior period — about 2.9 days to cover at its recent average daily volume. On November 5, 2026, 46.0% of MDT volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)139,004,337 shares as of October 15, 2026
Change vs prior period▲ 247.7%
Days to cover2.93 at avg daily volume of 47,498,393
Daily short volume (FINRA facilities)46.0% of 4,794,646 shares on November 5, 2026
5-day average short volume44.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with M →
$102.24 -2.48% today
52-week range · as of 2026-10-07 $73.31 – $106.33
Market cap
$130.78B
Volume
3.4M (0.1× avg)
3-mo avg 25.6M
Live data · 2026-11-06 19:49 UTC · Market open

show_chartPrice Chart

Loading chart...

feed MDT - Latest Insights

MDT
Oct 15, 2026, 10:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $94.90
Real-time Price: $102.24 info
Change: +$7.34 (+8%) info
Market Cap: $130.782B info
MDT
Oct 12, 2026, 9:22 AM EDT
Source: Seeking Alpha
Importance Score:
8
Updated Oct 14, 8:07 AM ET — Final proration factor set at 18.289133%; 297,521,390 shares validly tendered, 55,032,401 accepted.
Price at Filing: $90.76
Real-time Price: $102.24 info
Change: +$11.48 (+13%) info
Market Cap: $130.782B info
MDT
Oct 07, 2026, 5:02 PM EDT
Filing Type: 425
Importance Score:
7
Price at Filing: $85.65
Real-time Price: $102.24 info
Change: +$16.59 (+19%) info
Market Cap: $130.782B info
MDT
Sep 14, 2026, 8:00 AM EDT
Filing Type: SC TO-I
Importance Score:
9
Price at Filing: $94.41
Real-time Price: $102.24 info
Change: +$7.83 (+8%) info
Market Cap: $130.782B info
MDT
Sep 14, 2026, 7:40 AM EDT
Filing Type: 425
Importance Score:
9
Price at Filing: $93.00
Real-time Price: $102.24 info
Change: +$9.24 (+10%) info
Market Cap: $130.782B info
MDT
Sep 03, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $93.10
Real-time Price: $102.24 info
Change: +$9.14 (+10%) info
Market Cap: $130.782B info
MDT
Sep 02, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $92.25
Real-time Price: $102.24 info
Change: +$9.99 (+11%) info
Market Cap: $130.782B info
MDT
Sep 01, 2026, 6:55 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $94.98
Real-time Price: $102.24 info
Change: +$7.26 (+8%) info
Market Cap: $130.782B info
MDT
Sep 01, 2026, 6:47 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $95.02
Real-time Price: $102.24 info
Change: +$7.22 (+8%) info
Market Cap: $130.782B info
MDT
Sep 01, 2026, 6:40 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $92.50
Real-time Price: $102.24 info
Change: +$9.74 (+11%) info
Market Cap: $130.782B info
MDT
Aug 17, 2026, 4:33 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $90.35
Real-time Price: $102.24 info
Change: +$11.89 (+13%) info
Market Cap: $130.782B info
MDT
Aug 04, 2026, 1:49 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $85.94
Real-time Price: $102.24 info
Change: +$16.30 (+19%) info
Market Cap: $130.782B info
MDT
Jul 13, 2026, 3:14 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $83.67
Real-time Price: $102.24 info
Change: +$18.57 (+22%) info
Market Cap: $130.782B info
MDT
Jun 19, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $79.10
Real-time Price: $102.24 info
Change: +$23.14 (+29%) info
Market Cap: $130.782B info
MDT
Jun 18, 2026, 4:35 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $79.81
Real-time Price: $102.24 info
Change: +$22.43 (+28%) info
Market Cap: $130.782B info
MDT
Jun 18, 2026, 4:27 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $79.81
Real-time Price: $102.24 info
Change: +$22.43 (+28%) info
Market Cap: $130.782B info
MDT
Jun 12, 2026, 11:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $80.22
Real-time Price: $102.24 info
Change: +$22.02 (+27%) info
Market Cap: $130.782B info
MDT
Jun 08, 2026, 12:05 PM EDT
Source: ACCESS Newswire
Importance Score:
7
Price at Filing: $80.46
Real-time Price: $102.24 info
Change: +$21.78 (+27%) info
Market Cap: $130.782B info
MDT
Jun 04, 2026, 3:13 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $78.21
Real-time Price: $102.24 info
Change: +$24.03 (+31%) info
Market Cap: $130.782B info
MDT
Jun 03, 2026, 12:20 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $77.38
Real-time Price: $102.24 info
Change: +$24.86 (+32%) info
Market Cap: $130.782B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets